Skip to content

Terms of Use

Blonde woman

The website www.opzelura.co.uk and related websites linked from this notice are provided by Incyte Biosciences International Sàrl (“Incyte”).

PLEASE READ AND REVIEW THE FOLLOWING TERMS CAREFULLY BEFORE USING THE WEBSITE

The following terms govern your use of the website, and by using the website you agree to be bound by and comply with these terms. If you do not agree to this, you may not be able to access or use the website. Incyte reserves the right to change these Terms from time to time without notice.

Use of the website

While Incyte makes reasonable efforts to post current and accurate information on the Website, INCYTE MAKES NO REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, REGARDING THE ACCURACY, COMPLETENESS OR SUITABILITY OF ANY INFORMATION PROVIDED ON THE WEBSITE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. THE INFORMATION ON THE WEBSITE IS PROVIDED TO YOU “AS IS”. Incyte disclaims all liability in connection with the use of the website or any website linked to this notice. Incyte is under no obligation to update the Website. Your access and use of the website, including but not limited to the information made available on the website, is at your own risk. You agree that you will not bring any claim against Incyte as a result of your access to or use of, or your inability to use, the Website or its content. Incyte shall not be liable in any way for any direct, indirect, consequential, incidental, special, or punitive damages arising out of your access, use, or inability to use the Website or its content, or any errors or omissions in its content, including, but not limited to any loss of use, data or profits, whether the action is based in contract, negligence or any other breach of law. The website and the information contained or referred to on the website are for informational, personal and non-commercial use only. The Website does not provide medical or professional services or advice and should not be relied upon in making any healthcare decisions. Individuals requiring diagnosis or treatment, or who have specific questions regarding an individual are urged to contact their healthcare provider. This website is intended for use by healthcare professionals in the UK. You should not construe anything on the Website as an advertisement or solicitation for any product or service that is not authorized by the laws and regulations of the jurisdiction in which you are located. The website or its content may not be used for any unlawful purpose.

Copyright and Other Intellectual Property Rights

The Website and the information contained on it, unless otherwise indicated, are the property of Incyte and are protected from unauthorized reproduction and distribution by copyright laws, international conventions and other intellectual property laws. The trademarks, service marks, logos or other intellectual property displayed on the Site are owned by Incyte unless otherwise noted. Nothing on the Website should be construed as granting any license or right to any trademark, service mark, logo or other intellectual property right. All rights are reserved for the owners of respective trademarks, service marks, logos or other intellectual property, except as otherwise described in this document.

Links to Third Party Websites

We may provide you with links to third party websites that may be of interest to you. Such third party websites are governed by their own terms of use. Incyte does not monitor, approve, approve, endorse, guarantee or sponsor any information, conclusions, recommendations, products or services described on this website. Incyte shall have no responsibility or liability for the use of or access to such third party websites.

Information Submitted to Incyte

Should you submit any information (e.g., feedback, suggestions, ideas, or comments) to Incyte through the Site, such information, except for personally identifiable information, which is governed by Incyte’s Privacy Policy, will be treated as Incyte’s property and not considered confidential; Incyte is free to use, reproduce, disseminate, distribute and otherwise exploit this information without restriction and without compensation to you. Incyte is free to use any idea, concept, know-how, technique or method contained in this information for any purpose and in any manner. By submitting any such information, you warrant and represent that you are the owner of all rights in such information. Under no circumstances may you use the Incyte website or email or other addresses to send Incyte proprietary or confidential information of third parties.

Privacy Policy

See Incyte’s Privacy Policy for terms and disclosures related to the collection and use of your personal information.

No offer and no request

The information made available on the Website does not constitute, and is not being made available in connection with, any offer or solicitation to buy, sell, trade or enter into any transaction in Incyte securities. Investors should not rely on this information in making investment decisions.

Various

Incyte reserves the right to change the content of the website at any time and without notice. Incyte reserves the right to terminate your access to or use of the Website at any time. You shall indemnify and hold harmless Incyte from any related liability, loss, damage and expense if you cause harm to others by breaching these Terms. These Terms constitute the entire agreement between you and Incyte relating to the subject matter hereof.

UNITED KINGDOM
Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Incyte immediately by calling 03301003677 (Great Britain) 00-800-0002-7423 (United Kingdom (Northern Ireland)).

REPUBLIC OF IRELAND
Adverse events should be reported. Reporting forms and information can be found at: HPRA Pharmacovigilance website: www.hpra.ie Adverse events should also be reported to Incyte by calling 00-800-0002-7423.